Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-12 10:40 am Purchase | 13G | vTv Therapeutics Inc. VTVT | FMR LLC | 178,200 7.324% | 178,200 (New Position) | View |
2024-03-22 4:57 pm Purchase | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 1,535,685 50.300% | 1,535,685 (New Position) | View |
2024-03-05 7:52 pm Purchase | 13D | vTv Therapeutics Inc. VTVT | Samsara BioCapital L.P. | 265,620 10.400% | 265,620 (New Position) | View |
2024-03-05 4:24 pm Purchase | 13D | vTv Therapeutics Inc. VTVT | BAKER BROS. ADVISORS LP | 122,664 4.990% | 122,664 (New Position) | View |
2022-08-23 3:10 pm Purchase | 13G | vTv Therapeutics Inc. VTVT | Medpace Investors LLC | 5,397,529 5.160% | 5,397,529 (New Position) | View |
2022-06-10 4:15 pm Purchase | 13D | vTv Therapeutics Inc. VTVT | G42 Investments AI Holdings RSC Ltd. | 10,386,274 13.400% | 10,386,274 (New Position) | View |
2022-06-01 4:05 pm Sale | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 61,427,396 60.100% | -87,000 (-0.14%) | View |
2021-11-12 4:46 pm Unchanged | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 61,514,396 67.000% | 0 (Unchanged) | View |
2021-09-17 4:01 pm Unchanged | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 61,514,396 72.300% | 0 (Unchanged) | View |
2020-12-17 5:02 pm Unchanged | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 61,514,396 79.300% | 0 (Unchanged) | View |
2020-12-10 4:45 pm Unchanged | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 61,514,396 79.300% | 0 (Unchanged) | View |
2020-11-24 4:45 pm Unchanged | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 61,514,396 79.300% | 0 (Unchanged) | View |
2020-05-12 4:30 pm Unchanged | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 61,514,396 85.300% | 0 (Unchanged) | View |
2020-02-25 4:31 pm Unchanged | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 61,514,396 85.300% | 0 (Unchanged) | View |
2020-01-28 4:31 pm Unchanged | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 61,514,396 85.300% | 0 (Unchanged) | View |
2020-01-07 4:15 pm Unchanged | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 61,514,396 85.300% | 0 (Unchanged) | View |
2019-12-23 4:15 pm Purchase | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 61,514,396 85.300% | 6,615,472 (+12.05%) | View |